BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 32280695)

  • 1. Identification of FOS as a Candidate Risk Gene for Liver Cancer by Integrated Bioinformatic Analysis.
    Hu JW; Ding GY; Fu PY; Tang WG; Sun QM; Zhu XD; Shen YH; Zhou J; Fan J; Sun HC; Huang C
    Biomed Res Int; 2020; 2020():6784138. PubMed ID: 32280695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dehydroepiandrosterone Activation of G-protein-coupled Estrogen Receptor Rapidly Stimulates MicroRNA-21 Transcription in Human Hepatocellular Carcinoma Cells.
    Teng Y; Radde BN; Litchfield LM; Ivanova MM; Prough RA; Clark BJ; Doll MA; Hein DW; Klinge CM
    J Biol Chem; 2015 Jun; 290(25):15799-15811. PubMed ID: 25969534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of invasion-metastasis-associated microRNAs in hepatocellular carcinoma based on bioinformatic analysis and experimental validation.
    Lou W; Chen J; Ding B; Chen D; Zheng H; Jiang D; Xu L; Bao C; Cao G; Fan W
    J Transl Med; 2018 Sep; 16(1):266. PubMed ID: 30268144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of potential miRNA-mRNA regulatory network contributing to pathogenesis of HBV-related HCC.
    Lou W; Liu J; Ding B; Chen D; Xu L; Ding J; Jiang D; Zhou L; Zheng S; Fan W
    J Transl Med; 2019 Jan; 17(1):7. PubMed ID: 30602391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of core genes and outcomes in hepatocellular carcinoma by bioinformatics analysis.
    Shen S; Kong J; Qiu Y; Yang X; Wang W; Yan L
    J Cell Biochem; 2019 Jun; 120(6):10069-10081. PubMed ID: 30525236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioinformatics analysis to identify the key genes affecting the progression and prognosis of hepatocellular carcinoma.
    Zhang Y; Wang S; Xiao J; Zhou H
    Biosci Rep; 2019 Feb; 39(2):. PubMed ID: 30705088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel microRNAs expression signature for hepatocellular carcinoma diagnosis and prognosis.
    Lu M; Kong X; Wang H; Huang G; Ye C; He Z
    Oncotarget; 2017 Jan; 8(5):8775-8784. PubMed ID: 28060739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-101 regulates expression of the v-fos FBJ murine osteosarcoma viral oncogene homolog (FOS) oncogene in human hepatocellular carcinoma.
    Li S; Fu H; Wang Y; Tie Y; Xing R; Zhu J; Sun Z; Wei L; Zheng X
    Hepatology; 2009 Apr; 49(4):1194-202. PubMed ID: 19133651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic implications of aberrantly expressed methylation‑driven genes in hepatocellular carcinoma: A study based on The Cancer Genome Atlas.
    Li J; Chen N; Gong X
    Mol Med Rep; 2019 Dec; 20(6):5304-5314. PubMed ID: 31661127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential role of microRNA‑223‑3p in the tumorigenesis of hepatocellular carcinoma: A comprehensive study based on data mining and bioinformatics.
    Zhang R; Zhang LJ; Yang ML; Huang LS; Chen G; Feng ZB
    Mol Med Rep; 2018 Feb; 17(2):2211-2228. PubMed ID: 29207133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insights into the etiology-associated gene regulatory networks in hepatocellular carcinoma from The Cancer Genome Atlas.
    Seshachalam VP; Sekar K; Hui KM
    J Gastroenterol Hepatol; 2018 Dec; 33(12):2037-2047. PubMed ID: 29672926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioinformatics Analysis of Prognostic Tumor Microenvironment-Related Genes in the Tumor Microenvironment of Hepatocellular Carcinoma.
    Tian Z; Wang Z; Chen Y; Qu S; Liu C; Chen F; Ma L; Zhu J
    Med Sci Monit; 2020 Mar; 26():e922159. PubMed ID: 32231177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significantly different expression levels of microRNAs associated with vascular invasion in hepatocellular carcinoma and their prognostic significance after surgical resection.
    Song SK; Jung WY; Park SK; Chung CW; Park Y
    PLoS One; 2019; 14(9):e0216847. PubMed ID: 31513595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Hepatocellular Carcinoma-Related Potential Genes and Pathways Through Bioinformatic-Based Analyses.
    Wan Z; Zhang X; Luo Y; Zhao B
    Genet Test Mol Biomarkers; 2019 Nov; 23(11):766-777. PubMed ID: 31633428
    [No Abstract]   [Full Text] [Related]  

  • 15. Screening key miRNAs for human hepatocellular carcinoma based on miRNA-mRNA functional synergistic network.
    Zhang CJ; Du HJ
    Neoplasma; 2017; 64(6):816-823. PubMed ID: 28895405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and interaction analysis of key genes and microRNAs in hepatocellular carcinoma by bioinformatics analysis.
    Mou T; Zhu D; Wei X; Li T; Zheng D; Pu J; Guo Z; Wu Z
    World J Surg Oncol; 2017 Mar; 15(1):63. PubMed ID: 28302149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated analysis of miRNA, gene, and pathway regulatory networks in hepatic cancer stem cells.
    Ding M; Li J; Yu Y; Liu H; Yan Z; Wang J; Qian Q
    J Transl Med; 2015 Aug; 13():259. PubMed ID: 26259570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of novel biomarkers for hepatocellular carcinoma using transcriptome analysis.
    Xia Q; Li Z; Zheng J; Zhang X; Di Y; Ding J; Yu D; Yan L; Shen L; Yan D; Jia N; Chen W; Feng Y; Wang J
    J Cell Physiol; 2019 Apr; 234(4):4851-4863. PubMed ID: 30272824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of potential key genes in very early hepatocellular carcinoma.
    Wu M; Liu Z; Li X; Zhang A; Lin D; Li N
    World J Surg Oncol; 2019 May; 17(1):77. PubMed ID: 31043166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance.
    Shi KQ; Lin Z; Chen XJ; Song M; Wang YQ; Cai YJ; Yang NB; Zheng MH; Dong JZ; Zhang L; Chen YP
    Oncotarget; 2015 Sep; 6(28):25093-108. PubMed ID: 26231037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.